(Fort Worth, TX) --- Michael E. Steadman, President of HEALTHPOINT®, Ltd., Tissue Management, an affiliate of Fort Worth-based DFB Pharmaceuticals, Inc., has announced that Robert E. Bancroft has joined the Tissue Management division of Healthpoint as Vice President, Marketing.

         Mr. Bancroft was formerly senior marketing director for Global BOTOX® at Allergan, Inc. BOTOX has been one of the most successful therapeutics worldwide, a franchise that exceeds $500 million annually.

         HEALTHPOINT, founded in 1992, is a specialty pharmaceutical company focusing on the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices worldwide. Its Tissue Management (TM) business includes marketing prescription drugs and innovative prescription technologies and devices for skin and soft tissue, including the treatment of acute and chronic tissue compromises and full and partial thickness wounds, and for the management of intact skin.

         “Rob’s in-depth background and experience in pharmaceutical and biologic development and marketing will enrich HEALTHPOINT’s commitment to pharmaceuticals and biologics for wound care,” said Mr. Steadman. “He had enormous success at Allergan due to his strategic vision and leadership. At Healthpoint, these two vital characteristics will be critical to achieving our excellent growth plans and strengthening our commitment to succession planning.”

         Current marketing focus at HEALTHPOINT TM is on incontinence related skin problems; chronic wounds such as pressure, venous, and diabetic ulcers, and associated skin conditions like peri-wound dermatitis and maceration; and on unique therapies for burns.

         “HEALTHPOINT has an energizing and unique vision – to develop differentiated pharmaceutical and biological technologies to address the very substantial unmet needs in wound care,” said Mr. Bancroft. “I look forward to contributing to the realization of that vision.”

         While at Allergan, Mr. Bancroft contributed to the significant success of the BOTOX business by overhauling the therapeutic business plan, defining the global competitive strategy, and leading a cross functional team in developing the life cycle management roadmap for the franchise.

         Mr. Bancroft began his career in sales of topical ophthalmics for Allergan’s U.S. Eye Care business in the late 1980’s before rising to senior director of global marketing.

         A 1987 graduate of Indiana University in Bloomington with a Bachelor of Science degree in biology, Mr. Bancroft completed his Master of Business Administration in marketing and finance in 1996 at the University of Southern California, Los Angeles.

         Since its inception, HEALTHPOINT has established a U.S. presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for tissue management, dermatology, and surgical. An aggressive research and development effort has brought HEALTHPOINT’s unique technologies to the market, setting the pace for its highly trained field sales organization of direct sales representatives. HEALTHPOINT, with over 300 employees, is a DFB Pharmaceuticals, Inc. affiliate company. Visit www.healthpoint.com

         Also headquartered in Fort Worth, DFB provides technology-driven products, outsourcing services, and licensing opportunities to the healthcare industry worldwide through its affiliate companies, contract partners, and branded marketing organizations. DFB is on the web at www.dfb.com.

###